Page last updated: 2024-08-25

triphenylacetic acid and Anemia, Sickle Cell

triphenylacetic acid has been researched along with Anemia, Sickle Cell in 1 studies

*Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arrington, S; Burns, JF; Creech, C; de Franceschi, L; McNaughton-Smith, GA; Rigdon, GC; Shelton, T; Stocker, JW1

Other Studies

1 other study(ies) available for triphenylacetic acid and Anemia, Sickle Cell

ArticleYear
Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
    Journal of medicinal chemistry, 2008, Feb-28, Volume: 51, Issue:4

    Topics: Acetamides; Anemia, Sickle Cell; Animals; Biological Availability; Clotrimazole; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Mice; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trityl Compounds

2008